A New Perspective for the Treatment of Alzheimer’s Disease: Exosome-like Liposomes to Deliver Natural Compounds and RNA Therapies
With the increment of the aging population in recent years, neurodegenerative diseases exert a major global disease burden, essentially as a result of the lack of treatments that stop the disease progression. Alzheimer’s Disease (AD) is an example of a neurodegenerative disease that affects millions...
Main Authors: | Joana Ribeiro, Ivo Lopes, Andreia Castro Gomes |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-08-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/28/16/6015 |
Similar Items
-
Biomembrane-Derived Nanoparticles in Alzheimer’s Disease Therapy: A Comprehensive Review of Synthetic Lipid Nanoparticles and Natural Cell-Derived Vesicles
by: Gao C, et al.
Published: (2023-12-01) -
Extracellular Vesicle Delivery of Neferine for the Attenuation of Neurodegenerative Disease Proteins and Motor Deficit in an Alzheimer’s Disease Mouse Model
by: Bin Tang, et al.
Published: (2022-01-01) -
Exosomes: vehicles for the transfer of toxic proteins associated with neurodegenerative diseases?
by: Shayne Anthony Bellingham, et al.
Published: (2012-05-01) -
Exosomes: A missing link between chronic systemic inflammation and Alzheimer’s disease?
by: Mehmet Ozansoy, et al.
Published: (2023-03-01) -
Current and Future Nano-Carrier-Based Approaches in the Treatment of Alzheimer’s Disease
by: Astik Kumar, et al.
Published: (2023-01-01)